PTSM: Pharmaceutical Technology Sourcing and Management-11-05-2014

Industry veteran Peter Bigelow to guide PBOA Board.

Supply chain security and quality group Rx-360 driven by patient safety.

As the number of CMOs shrinks due to acquisitions, exits, compliance problems and a switch to proprietary products, the capacity available to industry is reduced.

The European Union takes the lead in a global pilot project on the marketing approval of generic medicines, highlighting the challenges of achieving consensus among different nations.

New assays, as well as advances in mass spectrometry and chromatography, give analytical testing laboratories tools to provide drug sponsors with additional information.

Fluorination can significantly impact the bioavailability of drug substances, however, safer fluorinating reagents and access to GMP fluorination capabilities remain challenges.

The Brazilian economy is being impacted by internal and external factors, and forecast figures are being quickly revised downwards.

Technologies, such as high-throughput screening and single-use systems, are facilitating the development and manufacture of large-molecule drugs.